Home » Blog » Mo1836 RESULTS AT 52 WEEKS OF INTRAVENOUS USTEKINUMAB MAINTENANCE TREATMENT IN PATIENTS WITH LOSS OF RESPONSE TO SUBCUTANEOUS DOSES: A MULTICENTER OBSERVATIONAL RETROSPECTIVE STUDY.

Blog

Mo1836 RESULTS AT 52 WEEKS OF INTRAVENOUS USTEKINUMAB MAINTENANCE TREATMENT IN PATIENTS WITH LOSS OF RESPONSE TO SUBCUTANEOUS DOSES: A MULTICENTER OBSERVATIONAL RETROSPECTIVE STUDY.

reviewer4you.com

9 May 2024

1 View 0

SaveSavedRemoved 0

Mo1836 RESULTS AT 52 WEEKS OF INTRAVENOUS USTEKINUMAB MAINTENANCE TREATMENT IN PATIENTS WITH LOSS OF RESPONSE TO SUBCUTANEOUS DOSES: A MULTICENTER OBSERVATIONAL RETROSPECTIVE STUDY.